Latest Going Concern News

Page 9 of 46
SOCO Corporation reports a 12% revenue drop to $9.7 million for H1 FY26, weighed down by a $4.6 million goodwill impairment linked to AxSym. Despite growth in core consulting, the company posted a significant net loss and undertook restructuring to align costs.
Victor Sage
Victor Sage
27 Feb 2026
Fat Prophets Global Contrarian Fund Ltd reported a dramatic turnaround with a $9.3 million profit for the half-year ended December 2025, up from just $14,000 a year earlier, alongside a declared interim dividend.
Claire Turing
Claire Turing
27 Feb 2026
Botanix Pharmaceuticals reports a surge in Sofdra sales driving revenue to $16.5 million, yet the company records a $33.2 million loss amid expanded marketing and operational costs. A $45 million capital raise aims to support growth and supply chain improvements.
Ada Torres
Ada Torres
27 Feb 2026
I Synergy Group Limited reported a 15.63% drop in revenue to AUD 0.81 million for FY2025, alongside a 21.5% increase in net loss to AUD 0.34 million, with auditors flagging going concern uncertainties.
Sophie Babbage
Sophie Babbage
27 Feb 2026
ASF Group Limited has reversed a significant loss to report a half-year profit of $539,708, driven by key disposals and a strengthened balance sheet.
Victor Sage
Victor Sage
27 Feb 2026
Synertec Corporation Limited reported a 20% increase in revenue to $10.2 million for the half-year ended 31 December 2025, alongside a 40% improvement in net loss after tax. The company’s Powerhouse renewable energy system continues to gain traction, supported by strategic partnerships and expanded manufacturing.
Maxwell Dee
Maxwell Dee
27 Feb 2026
CONNEQT Health reported a 40% revenue increase to $2.28 million for the half-year ending December 2025, driven by strong sales of its CONNEQT Pulse device and early subscription uptake. Despite narrowing its net loss by 14%, the company continues to navigate operational restructuring and funding challenges as it pivots towards a recurring revenue model.
Ada Torres
Ada Torres
27 Feb 2026
Skin Elements Limited reported a $4.01 million loss for the half-year ending December 2025, alongside a 41% revenue drop, while securing $2.5 million in fresh capital to advance its proprietary SE Formula biotechnology products.
Ada Torres
Ada Torres
27 Feb 2026
Burgundy Diamond Mines reported a net loss of $86.8 million for 2025, reflecting operational challenges including the suspension of Point Lake mining due to adverse tariffs. The company secured $83.4 million in Canadian tariff relief financing to bolster liquidity and restructured its debt amid ongoing market uncertainties.
Maxwell Dee
Maxwell Dee
27 Feb 2026
PainChek Limited reported a half-year loss of AUD 4.7 million but achieved a major regulatory milestone with FDA clearance for its Adult App, unlocking significant US market opportunities. The company also completed a share consolidation and raised capital to support growth.
Ada Torres
Ada Torres
27 Feb 2026
NoviqTech Limited reported a widening loss of $2.83 million for 2025, alongside a severe drop in cash reserves and a looming going concern uncertainty flagged in its upcoming audit.
Sophie Babbage
Sophie Babbage
27 Feb 2026
RocketBoots Limited reported a steep 71.75% drop in profit after tax to a $2.36 million loss for the half-year ending December 2025, despite a modest revenue increase. The company’s future hinges on a transformative $9.1 million annual recurring revenue contract with a tier-one multinational retailer and a recent $7 million capital raise.
Sophie Babbage
Sophie Babbage
27 Feb 2026